DK0656906T3 - Endothelcellemolekyle, der medierer lymfocytbinding i mennesket - Google Patents

Endothelcellemolekyle, der medierer lymfocytbinding i mennesket

Info

Publication number
DK0656906T3
DK0656906T3 DK93913035T DK93913035T DK0656906T3 DK 0656906 T3 DK0656906 T3 DK 0656906T3 DK 93913035 T DK93913035 T DK 93913035T DK 93913035 T DK93913035 T DK 93913035T DK 0656906 T3 DK0656906 T3 DK 0656906T3
Authority
DK
Denmark
Prior art keywords
man
vap
endothelial cell
cell molecule
lymphocyte binding
Prior art date
Application number
DK93913035T
Other languages
English (en)
Inventor
Sirpa Jalkanen
Marko Salmi
Original Assignee
Biotie Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25404388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0656906(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biotie Therapies Oy filed Critical Biotie Therapies Oy
Application granted granted Critical
Publication of DK0656906T3 publication Critical patent/DK0656906T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK93913035T 1992-06-09 1993-06-09 Endothelcellemolekyle, der medierer lymfocytbinding i mennesket DK0656906T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89535492A 1992-06-09 1992-06-09
PCT/FI1993/000250 WO1993025582A1 (en) 1992-06-09 1993-06-09 A novel endothelial cell molecule mediating lymphocyte binding in man

Publications (1)

Publication Number Publication Date
DK0656906T3 true DK0656906T3 (da) 1999-12-20

Family

ID=25404388

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93913035T DK0656906T3 (da) 1992-06-09 1993-06-09 Endothelcellemolekyle, der medierer lymfocytbinding i mennesket

Country Status (14)

Country Link
EP (1) EP0656906B1 (da)
JP (2) JP3431922B2 (da)
KR (1) KR100268772B1 (da)
AT (1) ATE184315T1 (da)
AU (1) AU671837B2 (da)
CA (1) CA2137551C (da)
DE (1) DE69326347T2 (da)
DK (1) DK0656906T3 (da)
ES (1) ES2135480T3 (da)
FI (1) FI121176B (da)
GR (1) GR3031255T3 (da)
HU (1) HU217175B (da)
NZ (2) NZ299958A (da)
WO (1) WO1993025582A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2204838C2 (ru) * 1997-05-23 2003-05-20 Байотай Терапис Лтд. Сосудистый белок - 1 адгезии, обладающий аминооксидазной активностью
FI20020807A0 (fi) * 2002-04-29 2002-04-29 Biotie Therapies Oyj Uusia humanisoituja anti-VAP-1 monoklonaalisia vasta-aineita
FI20061156A0 (fi) 2006-12-27 2006-12-27 Elina Kivi Uusia peptidejä
FI20075278A0 (fi) * 2007-04-20 2007-04-20 Biotie Therapies Corp Uudet täysin ihmisperäiset anti-VAP-1 monoklonaaliset vasta-aineet

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2165461A1 (en) * 1993-06-18 1995-01-05 Sirpa Jalkanen Compositions and diagnostic methods using monoclonal antibodies against cd44v6

Also Published As

Publication number Publication date
AU671837B2 (en) 1996-09-12
ES2135480T3 (es) 1999-11-01
JP3500384B2 (ja) 2004-02-23
HU217175B (hu) 1999-12-28
KR950701938A (ko) 1995-05-17
WO1993025582A1 (en) 1993-12-23
FI20095269L (fi) 2009-03-16
DE69326347T2 (de) 2000-02-24
HUT75824A (en) 1997-05-28
AU4328193A (en) 1994-01-04
JPH07507557A (ja) 1995-08-24
JP2003180346A (ja) 2003-07-02
FI121176B (fi) 2010-08-13
GR3031255T3 (en) 1999-12-31
ATE184315T1 (de) 1999-09-15
DE69326347D1 (de) 1999-10-14
NZ253151A (en) 1997-03-24
EP0656906B1 (en) 1999-09-08
HU9403516D0 (en) 1995-02-28
NZ299958A (en) 2000-07-28
CA2137551C (en) 2002-03-26
JP3431922B2 (ja) 2003-07-28
KR100268772B1 (ko) 2000-10-16
CA2137551A1 (en) 1993-12-23
EP0656906A1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
ATE208820T1 (de) Humanisierte antikoerper
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
EP0728215A4 (en) METHOD FOR BINDING MATERIAL TO THE -g (b) AMYLOID PEPTIDE
DK0724456T3 (da) CD40-Antistoffer
ATE218387T1 (de) Antikörperreinigung
DK0673255T3 (da) Monoklonale antistoffer, som specifikt binder til vaskulært tumorendotel, og anvendelser deraf
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
DE69531679D1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
NO20083805L (no) Anvendelse av et antistoff som binder Aβ-peptidsekvenser
FI893575A0 (fi) Antigenstrukturer av çmajor histocompatibility complexç antigener av klass i med specifika baerarmolekyler, framstaellning och anvaendning daerav.
MY154009A (en) Anti-alpha v beta 6 antibodies
ATE425989T1 (de) Proteinreinigungsverfahren
KR950700779A (ko) 단백질의 정제방법(Protein purification)
NO942912L (no) Konstruksjon, kloning og ekspresjon av humaniserte, monoklonale antistoffer mot humant interleukin-5
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
MX9704897A (es) Secuencias del anticuerpo anti-idiotipo monoclonal recombinante 3h1 relacionadas con el antigeno carcinoembrionico humano.
DE69028513D1 (de) Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
DE59107756D1 (de) Monoklonale Antikörper gegen Melanom
BG40318A3 (en) Method for preparing imunoglobuline derivatives of vindezine
EP1411962A4 (en) TREATMENT OF PANCREATIC CANCER WITH A MONOCLONAL ANTIBODY
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DK0840620T3 (da) IL-8-antagonister til behandling af astma
DK0493446T3 (da) Behandling af autoimmunsygdom.
HUT75824A (en) A novel endothelial cell molecule mediating lymphocyte binding in man
DE69227918D1 (de) VERWENDUNG EINES CDw52-SPEZIFISCHEN ANTIKÖRPERS ZUR BEHANDLUNG VON DURCH T-ZELLEN VERMITTELTEN GELENKENTZÜNDUNGEN